FDA Chafes At Drugmaker's Graphic Design In Promo Piece
The U.S. Food and Drug Administration's Office of Prescription Drug Promotion posted on Monday an "untitled letter" — its third this year — to Althera Pharmaceuticals LLC, objecting to the portrayal...To view the full article, register now.
Already a subscriber? Click here to view full article